Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 1:06 PM
Ignite Modification Date:
2025-12-24 @ 1:06 PM
NCT ID:
NCT07147361
Eligibility Criteria:
Inclusion Criteria:
1. Patients with pathologically confirmed esophageal squamous cell carcinoma (ESCC), head and neck squamous cell carcinoma (HNSCC), cervical squamous cell carcinoma (CSCC), or lung squamous cell carcinoma (LSCC), regardless of surgical eligibility
2. For surgically eligible patients: Planned to receive neoadjuvant PD-1 inhibitor ± chemotherapy as first-line treatment
3. For surgically ineligible patients: Planned to receive PD-1 inhibitor ± chemotherapy as first-line treatment
4. Availability of pre-treatment biopsy tissue and baseline blood samples
5. Capable of providing informed consent
Exclusion Criteria:
1. Patients with concurrent other types of malignancies
2. Patients who have already undergone prior antitumor therapy
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT07147361
Study Brief:
Protocol Section:
NCT07147361